Daily News Podcast

Alarming rate of diabetes medication discontinuations


 

Most patients with type 2 diabetes stop taking their medication within a year, and nearly one-third stop within the first 3 months. Also today, the FDA approves Ajovy for migraine prevention, some teens are using cannabis in their vapor devices, and alpha-blocker use is still common and still risky.


Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Lung function decline linked to cardiovascular risk
MDedge Neurology
Rivaroxaban beats aspirin for VTE
MDedge Neurology
New and Noteworthy Information—September 2018
MDedge Neurology
FDA approval for 2 HIV drugs
MDedge Neurology
ATTR-ACT shows treatment breakthrough in amyloid cardiomyopathy
MDedge Neurology
Modest alcohol and NAFLD
MDedge Neurology
Cardiovascular risk with diclofenac
MDedge Neurology
Baloxavir, oseltamivir similar for influenza
MDedge Neurology
New guidelines on prophylaxis for cancer-related immunosuppresion
MDedge Neurology
Urine drug screens show improper medication use
MDedge Neurology